MedTrace Logo

Clinical Assessment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and/or Chronic Heart Failure (CHF)

NCT01114386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2012-06-07

No results posted yet for this study

Summary

Cigarette smoking, the major risk factor for COPD, causes not only airway and lung inflammation, but also systemic effects. These systemic effects of smoking could substantially contribute to the development of chronic diseases, other than COPD, particularly chronic heart failure (CHF). The aim of this project is to assess the frequency and severity of CHF and COPD in outpatients with history of smoking referred to Hospital because of dyspnea and/or chronic cough.

Conditions

  • COPD
  • Heart Failure, Congestive

Interventions

PROCEDURE

Lung function testing, echocardiography, blood sampling

All patients will undergo to: * physical examination * 6' Minute Walk test * pulmonary function testing (spirometry + volumes and reversibility testing) * carbon monoxide diffusing capacity (DLCO) with single-breathe technique * ECG * echocardiography

Sponsors & Collaborators

  • Agenzia Italiana del Farmaco

    collaborator OTHER_GOV

  • University of Modena and Reggio Emilia

    lead OTHER

Principal Investigators

  • Leonardo M Fabbri, MD · University of Modena and Reggio Emilia

Eligibility

Min Age
50 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2011-07-31
Completion
2011-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01114386 on ClinicalTrials.gov